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Abstract: Background/Aim: Plants play an important role in anti-cancer drug discovery, therefore,
the current study aimed to evaluate the biological activity of Alpinia zerumbet (A. zerumbet) flowers.
Methods: The phytochemical and biological criteria of A. zerumbet were in vitro investigated as
well as in mouse xenograft model. Results: A. zerumbet extracts, specially CH2Cl2 and MeOH
extracts, exhibited the highest potent anti-tumor activity against Ehrlich ascites carcinoma (EAC) cells.
The most active CH2Cl2 extract was subjected to bioassay-guided fractionation leading to isolatation
of the naturally occurring 5,6-dehydrokawain (DK) which was characterized by IR, MS, 1H-NMR and
13C-NMR. A. zerumbet extracts, specially MeOH and CH2Cl2 extracts, exhibited significant inhibitory
activity towards tumor volume (TV). Furthermore, A. zerumbet extracts declined the high level of
malonaldehyde (MDA) as well as elevated the levels of superoxide dismutase (SOD) and catalase
(CAT) in liver tissue homogenate. Moreover, DK showed anti-proliferative action on different human
cancer cell lines. The recorded IC50 values against breast carcinoma (MCF-7), liver carcinoma (Hep-G2)
and larynx carcinoma cells (HEP-2) were 3.08, 6.8, and 8.7 µg/mL, respectively. Conclusion: Taken
together, these findings open the door for further investigations in order to explore the potential
medicinal properties of A. zerumbet.
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1. Introduction
Cancer is a complex group of diseases that is characterized by a rapid and uncontrolled formation
of abnormal cells, which may collect together to form a tumor. The development of cancer occurs
through a multistage process and driven by endogenous and environmental factors [1–4]. Oxidative
stress is the imbalance between the anti-oxidant enzymes production included superoxide dismutase
(SOD), catalase (CAT), and glutathione peroxidase (GPx) and the release of free radicals in the metabolic
or phagocytic process [5]. Oxidative stress causes damage to the DNA molecule, modifies signaling
pathways, and regulates progression of various types of cancers [6]. Cancer initiation and progression
has been combined to oxidative stress through increasing DNA mutations and damage, breakage of
genome structure, and induction of cell proliferation [7]. Due to the drawbacks of chemotherapeutic
treatment [8], medicinal plants and venoms play important roles in anti-cancer drug discovery [9–11].
Alpinia species are used as human food components with pharmaceutical effects in many countries.
In Asia is used to relieve fevers and malaria, as well as to act as general health improvements [12].
They are important natural resources for their use as spice crops [13]. In Japan, it is used to prepare a
traditional food, mu-chi, that prevents the common cold [14]. In China, it is employed to clear cold and
stimulate the spleen and stomach as well as in Brazil it is usually used as a drink to treat hypertension
and as water pill medication [15,16]. A. zerumbet (Zingiberaceae) species is originating in the East Indies
and is widespread in the tropical and subtropical regions of South America, Oceania, and Asia [17]. It
is used in traditional medicine to cure cardiovascular disorders, hypertension, inflammation, cold,
and as antispasmodic agent. Also, the essential oil possess anti-oxidant, relaxant, anti-spasmodic and
anti-cancer effects [18,19]. Moreover, A. zerumbet extract possessed anti-nociceptive, anti-pyretic, and
anti-inflammatory activites mediated by free radicals scavenging and inhibition of prostaglandins and
leukotrienes synthesis [20].
As part of the current ongoing research efforts, we wanted to exploit the opportunity of finding a
new potential anti-cancer entity using the unique set of Egyptian medicinal plants that are traditionally
used by the Bedouins of the Sinai desert. These plants have not been chemically investigated and
are known to have biological activities, which maximizes the chance of providing novel molecular
structures with promising cytotoxic and anti-oxidant effects. In this particular study we focused on
investigating the chemical components of the active fractions of A. zerumbet flowers. Also, the active
fractions were subjected to bioassay-guided protocol, developed for in vitro and in vivo studies prior
to the isolation of the bioactive ingredients [21]. The present study revealed that A. zerumbet extracts
possessed significant suppression effect against solid tumor volume. DK showed anti-proliferative
effect against different human cancer cell lines. In addition, the levels of MDA, SOD, and CAT in liver
tissue homogenates were regulated by the action of extracts.
2. Results
2.1. Cytotoxicity of Methanol Extracts of Fifteen Egyptian Medicinal Plants Species
The cytotoxicity of methanol (MeOH) extracts of Egyptian medicinal plants species was determined
using brine shrimp (Artemia salina). Results revealed that the methanol extracts of the species possessed
variable range of mortality against brine shrimp. Mortality percent of the fifteen plant species that
were evaluated in this screening were listed in Table 1. The flowers of A. zerumbet exhibited the most
potent activity among all the tested methanol extracts, with mortality rate of 93.33%.
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Table 1. Lethality of Egyptian medicinal plants’ MeOH extracts using brine shrimp (Artemia salina).
No. Plant Scientific Name Vernacular Name Part Used % Mortality
1 Alpinia zerumbet Variegated ginger Flowers 93.33
2 Anabasis setifera Agram, Asal, Glew ÐQj. «, ñÊg. , É« Flowers 43.33
3 Ballota undulata Ghassa, Zafra
èQ 	¯ 	P , é 	« Flowers 50.00
4 Calathea metallica ND Flowers 23.33
5 Caylusea hexagyna Danaban 	àAJ. 	KX Flowers 10.00
6 Echinops glaberrimus Khashir Q
  	k Flowers 56.66
7 E. spinosus Qatad, Gorreih l'
Qk. , XAJ¯ Flowers 86.66
8 Globularia arabica Handaqouq, zorreiqa
é®K
P 	P , ðY	Jk Flowers 46.66
9 Lavandula pubescens Atan 	á¢« Fruits 63.33
10 Psoralea mutisii ND Flowers 13.33
11 P. pubescens ND Flowers 6.66
12 Reseda arabica ND Flowers 30.00
13 Salvadora persica Araak, Siwaak, Miswaak ¼@ñÓ , ¼@ñ , ¼@P

@ Flowers 0.00
14 Salvia aegyptiaca Ra‘alah
éÊ«P Flowers 63.33
15 Senecio reflexun Morrar, Umm Lonein P@PQÓ, 	á
 	KñË Ð

@ Flowers 36.66
2.2. Cytotoxicity of A. zerumbet Extracts/Fractions
Since the MeOH extract of A. zerumbet showed the highest potent activity, bioassay-guided
fractionation was performed to isolate these cytotoxic bioactive compounds. A. zerumbet extract was
successively partitioned by hexane, CH2Cl2 and H2O. The bioactivity of A. zerumbet extracts/fractions
was detected using brine shrimp lethality. Results in Table 2 represented that the most significant
activity was displayed particularly in CH2Cl2 with mortality rate (100%). Also, the Bioassay-guided
fractionation resulted in the isolation of 5,6-dehydrokawain (DK).
Table 2. Bioactivity evaluation of A. zerumbet extracts/fractions using brine shrimp lethality.
Substance
Mortality %
Concentration
100 (µg/mL)
CH2Cl2 ex. 100.00
MeOH-H2O (90%) ex. 80.00
H2O ex. 50.00
Hexane ex. 50.00
Insoluble ex. 13.33
F1 100.00
F2 30.00
F3 20.00
F4 63.33
F5 86.66
DK 100.00
ex.: extract; F: fraction; DK: 5,6-dehydrokawain.
2.3. Structure Elucidation of DK
To find out the molecular structure of the active main compounds, CH2Cl2 extract was fractionated
using SEPARO-AGC, followed by bio-assay. Fraction 1 possessed the strongest activity causing brine
shrimp mortality of 100% (Table 2), therefore, the compound was isolated from fraction 1 as pale yellow
crystals with a molecular formula of C14H12O3, which was established by the EIMS (m/z 228 Da). Using
spectroscopic analysis, DK was identified as shown in Table 3 and chemical structure was illustrated in
Figure 1.
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13 CH 7.29,dd 128.4  
14 CH 7.29,dd 127.1  
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The cytotoxic activity of A. zerumbet extracts (crude MeOH, CH2Cl2, insoluble and H2O) was 
evaluated against EAC cells at three concentrations (25, 50, and 100 µg/mL) using trypan blue 
exclusion assay. Results in Figure 2 showed that the cytotoxic activity of the tested extracts was 
concentration dependent manner. The recorded activities of MeOH, CH2Cl2, insoluble and H2O 
extracts at 25 µg/mL were 80.5%, 91.3%, 45.5% and 30.5%, respectively, while at 50 µg/mL were 88.6%, 
94.7%, 60.6%, and 59%, respectively. The highest cytotoxic activities were observed at 100 µg/mL as 
followed 95.2%, 100%, 87.8% and 62.5%, respectively compared to that of vehicle control, 
dimethylsulfoxide (DMSO). 
 
Figure 2. The in vitro cytotoxic effect of A. zerumbet extracts. The cytotoxicity of A. zerumbet extracts 
(MeOH, CH2Cl2, insoluble and H2O) was evaluated against EAC cells using trypan blue exclusion 
Table 3. 1H and 13C-NMR data using CDCl3 solvent.
Position Type δH(ppm) δc(ppm) References
2 162.9
3 5.3,s 88.6 [22]
4 C − 170.7
5 CH 5.87,s 101 [23]
6 C − 158.6
7 CH 6.41,d 118.7 [24]
8 CH 7.39,d 135.4
9 C − 135.3 [25]
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2.4. In Vitro Cytotoxic Activity of A. zerumbet Extracts Against Ehrlich Ascities Carcinoma (EAC) Cells
The cytotoxic activity of A. zerumbet extracts (crude MeOH, CH2Cl2, insoluble and H2O) was
evaluated against EAC cells at three concentrations (25, 50, and 100 µg/mL) using trypan blue exclusion
assay. Results in Figure 2 showed that the cytotoxic activity of the tested extracts was concentration
dependent manner. The recorded activities of MeOH, CH2Cl2, insoluble and H2O extracts at 25 µg/mL
were 80.5%, 91.3%, 45.5% and 30.5%, respectively, while at 50 µg/mL were 88.6%, 94.7%, 60.6%, and
59%, respectively. The highest cytotoxic activities were observed at 100 µg/mL as followed 95.2%,
100%, 87.8% and 62.5%, respectively compared to that of vehicle control, dimethylsulfoxide (DMSO).
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Figure 2. The in vitro cytotoxic effect of A. zerumbet extracts. The cytotoxicity of A. zerumbet extracts
(MeOH, CH2Cl2, insoluble and H2O) was evaluated against EAC cells using trypan blue exclusion
assay. Three concentrations (25, 50, and 100 µg/mL) were added on the cells in triplicate and incubated
at 37 ◦C for 3 h in 5% CO2 atmosphere. Data was expressed as mean ± SEM from three independent
experiments. Significantly (* p < 0.001) different from the vehicle control (DMSO).
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2.5. Anti-Proliferative Activity of DK
Results in Figure 3 revealed that DK showed anti-proliferative activity against MCF-7, HEP-G2,
and HEP-2 cell lines (Figure 3A) with calculated IC50 values of 3.08, 6.8, and 8.7 µg/mL, respectively as
illustrated in Figure 3B. Conversely, DK didn’t show cytotoxic activity against normal human fibroblast
cell line (BHK) at the concentration range (1–10 µg/mL) as shown in Figure 3C.
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2.6. Effect of A. zerumbet Extracts on Tumor Volume (TV) 
All A. zerumbet extracts showed a significant (p < 0.001) reduction in TV in comparison to the 
control group (Figure 4). MeOH extract exhibited the most potent inhibitory effect (96.6%) followed 
by CH2Cl2 and insoluble extracts (79.6% and 63.2%, respectively) as compared to that of vehicle 
control (tumor + DMSO). 
Figure 3. Anti-proliferative activity of 5,6-dehydrokawain (DK) against MCF-7, HEP-G2, HEP-2, and
BHK cell lines. Cell viability was evaluated using MTT assay. (A) Dose-response curves, (B) IC50
values of DK against MCF-7, HEP-G2, and HEP-2, (C) Effect of DK against human normal fibroblast
(BHK). IC50 values were calculated from dose-response curves and represented as mean ± SME of three
independent experiments. Significantly (* p < 0.001) different from the vehicle control (DMSO).
2.6. Effect of A. zerumbet Extracts on Tumor Volume (TV)
All A. zerumbet extracts showed a significant (p < 0.001) reduction in TV in comparison to the
control group (Figur 4). MeOH extract exhibited he most potent inh bitory effect (96.6%) followed by
CH2C 2 and insol ble extracts (79.6% and 63.2%, respectively) as compared to that of vehicle c ntrol
(tumor + DMSO).
2.7. Effect of A. zerumbet Extracts on Malonaldehyde (MDA) Level
The levels of MDA in the liver tissue homogenate were measured as an indicator of lipid
peroxidation. As shown in Figure 5, MDA levels were significantly (p < 0.001) increased in mice
bearning solid tumor compared to those in the normal control group (untreatred). In contrast,
EAC-bearning mice treated with crude MeOH, CH2Cl2, and insoluble extracts exhibited a significant
(p < 0.001) reduction in MDA level compared to that of vehicle control group (tumor + DMSO).
Molecules 2019, 24, 2495 6 of 14
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Figure 4. The effect of A. zerumbet extracts (MeOH, CH2Cl2, and insoluble) on tumor volume (TV). TV
was calculated from the current equation: TV(mm3) = 0.52 × longest diameter × (shorter diameter)2.
Data was expressed as mean ± SEM. Significantly (# p < 0.001) different from the vehicle control
(tumor + DMSO).
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Figure 5. Effect of A. zerumbet extracts (MeOH, CH2Cl2, and insoluble) on malonaldehyde (MDA)
activity. MDA is an indicator of lipid peroxidation. MDA levels were assessed in liver homogenate,
data was represented as mean ± SEM and expressed as nmole/g tissue. Significantly (* p < 0.001)
different from the normal control (untreated) and Significantly (# p < 0.001) different from the vehicle
control (tumor + DMSO).
2.8. Effect of A. zerumbet Extracts on Superoxide Dismutase (SOD) Activity
Figure 6 illustrated that the level of SOD in the liver tissue homogenate was significantly declined
(p < 0.001) in tumor-bearing mice compared to normal control mice (untreated). On the other hand,
the treatment of mice bearning solid tumor with MeOH, CH2Cl2 and inso uble xtracts resulted
Molecules 2019, 24, 2495 7 of 14
in significant elevation (p < 0.001) and restoring the SOD level compared to that of vehicle control
(tumor + DMSO).
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Figure 6. Effect of A. zerumbet extracts (MeOH, CH2Cl2, and insoluble) on superoxide dismutase (SOD)
activity. SOD levels were assessed in liver homogenate, data was represented as mean ± SEM and
expressed as U/mg tissue. Significantly (* p < 0.001) different from the normal control (untreated) and
significantly (# p < 0.001) different from the vehicle control (tumor + DMSO).
2.9. Effect of A. zerumbet Extracts on Catalase (CAT) Activity
In comparison to normal control mice (untreated), the level of CAT in the liver tissue homogenate
was significantly declined (p < 0.001) in tumor-bearing mice as shown in Figure 7. Conversely, the
mice treated with MeOH, CH2Cl2 and insoluble extracts showed a significant (p < 0.001) elevation in
CAT level in relative to that of vehicle control group (tumor + DMSO).Molecules 2019, 24, x FOR PEER REVIEW 8 of 15 
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3. Discussion
Cancer is a leading cause of cancer-related deaths worldwide [26]. Surgery, radiation, and
chemotherapy are methods used for cancer treatment. Although many synthetic anti-cancer agents are
used in the treatment of cancer, the side effects and drug resistant still limited their use [27]. Therefore,
anti-cancer agents from natural products, particularly medicinal plants are desirable [28]. Medicinal
plants such as polyphenolic compounds and dietary polyphenols exhibited beneficial effects in human
health. As, they can induce prevention of cancers, cardiovascular and neurodegenerative diseases [29].
Several herbs possessing cancer-preventive properties has identified through the National Cancer
Institute [30].
In the current study fifteen Egyptian medicinal plants species (Table 1) have chosen since their
tested parts are known to contain polyphenolic compounds as well as different active ingredients that
may exhibited several biological functions. Table 1 revealed that the methanol extract of A. zerumbet
flowers exhibited the most potent activity among the studied fifteen Egyptian medicinal plants
extracts. The bioassay-guided fractionation for A. zerumbet extract was performed by hexane, CH2Cl2
and H2O and according to results in Table 2, CH2Cl2 extract exhibited the most significant activity.
The bioassay-guided fractionation of CH2Cl2 extract leaded to the isolation of DK (Figure 1) and its
chemical structure was elucidated by different spectroscopic methods (Table 3). Moreover, DK showed
anti-proliferative activity against MCF-7, HEP-G2, and HEP-2 as shown in Figure 3.
EAC tumor was primarily described as a spontaneous murine mammary adenocarcinoma [31]
with very aggressive growing in mice. Its ascites form has been used as a tumor model to examine the
anti-tumor effects of several substances [32]. Therefore, the cytotoxic activity of different A. zerumbet
extracts was evaluated against EAC cells. Results in Figure 2 showed that all extracts proven in vitro
cytotoxic activity specially, CH2Cl2 extract. Additionally, they possessed potent activity to reduce the
tumor mass in a mouse xenograft model according to results of Figure 4. This may be explained and
related to the presence of cytotoxic active compound, DK.
Under metabolic pathways and certain conditions, oxygen molecule generated undesirable
reactive oxygen species (ROS) such as superoxide anion and hydroxyl radicals as well as non-free
radical species as hydrogen peroxide. The excessive production of free radicals reported to induce lipid
peroxidation in vivo [33,34]. The MDA, the end product of lipid peroxidation, found to be a tumor
promoter which caused high toxicity and inhibition of some protective enzymes [35,36]. The excessive
amount of ROS can lead to many several diseases, including cancer [37]. Thus, the anti-oxidant effects
of the A. zerumbet extract in liver homogenate of mice bearing EAC-solid tumor was evaluated.
As shown in Figure 5, in EAC bearing mice, the level of lipid peroxide in liver was significantly
elevated, which was however reduced near to normal level in A. zerumbet extract treated mice. This
reflects the decline in free radical production and subsequent reduction in oxidative stress. MDA
found to be high in cancer tissues [38], which is compatible with our present results in untreated
EAC control groups. Moreover, several studies demonstrated the anti-lipid peroxidative action of
A. zerumbet [39–41], which is in agreement with our present results.
Enzymatic anti-oxidant mechanisms play a vital role in the removal of free radicals. SOD reported
as the first line of defense against superoxide anion and preventing its destructive effect. It is involved
in the clearance of superoxide anions. The inhibition of SOD activities as a result of tumor growth
was reported [42]. Results in Figure 6 showed a significant decrease in SOD level in EAC-bearing
mice when compared with treated groups, which is in agreement with other reported studies [43,44].
The administration of A. zerumbet significantly recovered the SOD level towards normal level.
The free radical scavenging enzyme, CAT, is existing in all oxygen-metabolizing cells and acts as
a direct defense against the potentially damaging reactivities of superoxide and hydrogen peroxide.
The inhibition of CAT activities as a result of tumor growth has also been reported [31]. According
to results illustrated in Figure 7, EAC tumor-bearing mice exhibited a significant decrease in CAT,
which is in agreement with that previously reported [45]. The administration of A. zerumbet increased
the CAT levels, which along with the restoration of lipid peroxide contents to near normal level
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indicate the anti-oxidant and free radical scavenging property of A. zerumbet and its potential use as
anti-cancer agent.
4. Materials and Methods
4.1. General Experimental Procedures
TLC was done on silica 60 F254 plates (0.25 mm; Merck, Munich, Germany), and detected with
UV light (254 and 366 nm). The melting point was measured using a Digital Melting Apparatus
(Model 1A 8103, Electrothermal Engineering Ltd., London, UK); IR spectrum was recorded using
a Perkin-Elmer 1600 FTIR spectrometer (Washington, WA, USA). HPLC/ESI-MS chromatograms
and spectra for dereplication were obtained on a Finnigan LCQ (San Jose, CA, USA) ion-trap mass
spectrometer coupled with an electro spray interface, and ÄKTA basic 10 HPLC systems (Amersham
Biosciences, Uppsala, Sweden). For LC-DAD-fractionation, a Shimadzu LC-10 system, equipped with
an SPD-M10AVP diode array detector, was employed. UV data were collected at 190 and 600 nm. It is
composed of a P-900 pump, UV-900 detector, Frac-900 fraction collector, with monitors at wavelengths
of 217, 254, and 335 nm. Accelerating gradient chromatography (AGC) was performed using variable
length AGC glass columns (Baeckström Separo AB, Lidingö, Sweden) with inner diameters of 4.00,
2.50, and 1.50 cm, packed with silica gel 60, 40–63 µm (Merck) and an FMI Lab pump, model QD (Fluid
Metering Inc., Oyster Bay, NY, USA), delivering a flow rate of 15–18 mL/min. Sample was eluted by a
continuous gradient flow running from hexane, through CH2Cl2, EtOAc, and MeOH to H2O. NMR
spectra were recorded on a Bruker DRX 600 spectrometer at 600.1 and at 150.9 MHz, respectively at
25 ◦C using CDCl3 as the solvent. All chemical shifts are expressed relative to TMS [46,47].
4.2. Plants Material
Plant specimens listed in (Table 1) were collected from the North, South Sinai, El-Menoufia and
different areas of Egypt between 2006 and 2009. The specimens were identified by Prof. Loutfy Boulos
(Department of Botany, Faculty of Science, Alexandria University, Alexandria, Egypt), and Prof. Zaki
Turki (Department of Botany, Faculty of Science, Menoufia University, Egypt). Voucher specimens
were deposited in the herbarium of the Department of Botany in the Faculty of Science, Menoufia
University, Egypt.
4.3. Extraction and Isolation
Plant materials were cut into small pieces and dried at room temperature. The dried material was
grounded to a coarse powder and extracted using MeOH (1 week) at room temperature three times in
succession with occasional stirring. The extracts were filtered and evaporated under reduced pressure.
All extracts were submitted to the biological assays, and based on initial screening; A. zerumbet was
selected for further analysis. A. zerumbet (300 g) was extracted three times (one week each) with
MeOH to give 34 g then partitioned between n-hexane, CH2Cl2, and H2O to give 4.9, 6, and 19.5 g,
respectively. CH2Cl2 extract (6 g) was adsorbed onto silica gel (12 g) and chromatographed on a silica
gel (28 g) column, eluted with continuous hexane-CH2Cl2, CH2Cl2-MeOH to MeOH gradients. Five
major fractions (F1:F5) were obtained. F1 was subjected to dereplication, HPLC fractionation, and
LC/ESI-MS to yield the pure compound (6 mg). The amount of the compound was 0.002 g for each
100 g of the dried plant.
4.4. Detection of the Cytotoxicity of Egyptian Medicinal Plants
The cytotoxicity of MeOH extracts of fifteen medicinal plants species and A. zerumbet extract
were assessed using brine shrimp lethality bioassay [48]. The extracts were examined in triplicate at
100 µg/mL in vials containing 5 mL of brine and 10 shrimp. The number of surviving shrimp after 24 h
was counted and the mortality percentage was calculated as the follows % of death = [(test-control)
/control] × 100. LD50 was derived from the best fit line obtained by linear regression analysis [49].
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4.5. Determination of the Cytotoxicity of A. zerumbet Extracts
The cytotoxic effect of crude MeOH, CH2Cl2, insoluble and H2O extracts of A. zerumbet were
determined in vitro against EAC cells using trypan blue dye exclusion method [50]. Cells viability were
assayed in the presence of three concentrations (25, 50, and 100 µg/mL). In details, EAC cells aspirated
aseptically from the peritoneal cavity of the mice and washed with Hank’s balanced salt solution
(HBSS) and centrifuged for 15 min at 1,500 rpm in a cooling centrifuge. The pellet re-suspended with
HBSS and the process repeated three times. Finally, the cells were suspended in known volume of
RPMI-1640, supplemented with 10% fetal bovine serum, 10 µg/mL streptomycin and 4 µg/mL penicillin;
the cell count adjusted to 2 × 106 cells/mL. Then, 0.2 mL of this diluted cell suspension titrated in 96
flat-bottomed tissue culture plates. Three concentrations (25, 50, and 100 µg/mL) were added on the
cells in triplicate and incubated at 37 ◦C for 3 h in 5% CO2 atmosphere. The total number of dead
and living cells was counted using a hemocytometer and cell viability/cytotoxicity percentage was
calculated [51].
4.6. Anti-Proliferative Activity of DK
4.6.1. Cell Lines and Cells Culture
HEP-G2 (human liver carcinoma), MCF-7 (humn breast carcinoma), HEP-2 (human larynx
carcinoma), and BHK (human normal fibroblast) were cultured in RPMI medium (Sigma-Aldrich,
St. Louis, MO, USA) supplemented with 10% fetal bovine serum (FBS, PAA Laboratories, Pasching,
Austria) in the presence of 100 IU/mL penicillin and 100 µg/mL streptomycin. The cells were maintained
at 37 ◦C in a humidified incubator with 5% CO2. Culture media were changed every two days with
new ones.
4.6.2. Proliferation Assay
The anti-proliferative activity of DK was determined using 3-(4,5-dimethylthiazol-2-yl)-2,5-
diphenyltetrazolium bromide (MTT) colorimetric assay. Cells were seeded at density of 5 × 103
cells/well in 96-well plates. After 24 h from seeding, the media were changed with new culture media
containg different concentration of DK (1–10 µg/mL). Post 24 h of DK addition, MTT (5 µL) were added
to the cells for 4 h. The formed formazan crystals were dissolved by adding 10% SDS containing 0.02 N
HCl for 24 h and then the absorbance was measured at 570 nm. Percentage of viability was calculated
compared to vehicle control (DMSO) and the half maximal growth inhibitory concentration (IC50) was
determined from the line equation of the dose-response curve.
4.7. In Vivo Studies
4.7.1. Tumor Cells
EAC cells were supplied by the National Cancer Institute, Cairo, Egypt. The cells were maintained
through interperitoneal (i.p) transplantation of 1 × 106 viable tumor cells in 1 mL of saline in normal
healthy mice by using 25G needle, to be used later for in vivo experiments.
4.7.2. Animals
Adult female Swiss albino mice (6–7 weeks old) with an average body weight of 25 g were used
in the present study. Mice were acclimatized for 7 days under standard laboratory conditions and
fed with libitum and water before commencement of the experimental protocol. The present study
protocol was approved by the Ethical Committee for Laboratory Animals of Science Faculty Menoufia
University (No.: ECLA-SFMU-10217).
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4.7.3. Mouse Xenograft Model
Solid tumors were induced in mice by subcutaneous injection of 0.2 mL of EAC cells (2 ×
106 cell/mL) [52]. Seven days after inoculation, the mice were randomly divided into 4 groups.
(1) MeOH group, (2) CH2CL2 group, (3) insoluble extract group and (4) control group: Groups 1, 2,
and 3 were treated subcutaneously with 100 µL of 250 mg/kg from MeOH, CH2Cl2, and insoluble
extracts, respectively daily for 5 consecutive days. The control group was treated with extracts vehicle
(0.03% DMSO). After treatment period, mice were euthanized then solid tumors and liver tissues
were dissected. The tumor volume (TV) was calculated using the following formula TV(mm3) =
0.52 × longest diameter × (shorter diameter)2 [53]. Liver tissue homogenate, (10% (w/v)) in potassium
phosphate buffer pH 7.4, were used for detection of MDA and SOD, CAT levels.
4.7.4. Estimation of MDA Levels in Liver Homogenate
MDA levels are an index of lipid peroxidation and were determined in the liver tissue homogenate
according to a previously reported method [54]. Briefly, thiobarbituric acid reacts with MDA in the
homogenate to form a thiobarbituric acid reactive product. The coloured product was measured at 534
nm and the results were expressed as nmol/g tissue.
4.7.5. Estimation of SOD Levels in Liver Homogenate
SOD, metalloenzyme, catalyzes the dismutation of the superoxide anion to molecular oxygen and
hydrogen peroxide. SOD activity was measured according to the Beyer method [55] and expressed as
U/mg tissue.
4.7.6. Estimation of CAT Levels in Liver Homogenate
CAT was determined in the liver tissue homogenate through the method of Aebi [56]. Briefly, CAT
reacted with a known quantity of H2O2 and after one minute the reaction was stopped. The remaining
H2O2 reacts with 4-aminophenazone to form a coloured product. CAT activity was measured and
expressed as U/mg tissue.
4.8. Statistical Analysis
Data are expressed as mean ± SEM and the statistical comparison between groups were analyzed
using one-way ANOVA followed by Tukey post hoc test (Graph Pad Software version 6, San Diego,
CA, USA). A p of < 0.05 value was considered statistically significant.
5. Conclusions
Our study revealed that A. zerumbet flowers were the most potent plant among the fifteen Egyptian
medicinal plants. A. zerumbet extracts showed potent anti-tumor effects against EAC. DK was isolated
from CH2Cl2 extract and characterized by different microscopic techniques. Additionally, A. zerumbet
extracts exhibited significant inhibitory activity towards TV as well as restored the levels of MDA, SOD,
and CAT in liver tissue homogenates. DK exhibited anti-proliferative activity against different human
cancer cell lines. Further investigations were required to explore the potential medicinal mechanisms
and clinical application of A. zerumbet.
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